OpGen, Inc. Stock News

GAITHERSBURG, Md., Oct. 29, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third

GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Oct. 28, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and

Shares of Maryland-based OpGen Inc. undefined rocketed 43% in active premarket trading Thursday, after the molecular diagnostics company said its...

Shares of OpGen (NASDAQ:OPGN) rose 4.98% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 226.67% over the past year to ($0.49), which beat

* Total Revenue for Q2 2020 was approximately $1.2 million dollars * Balance sheet strengthened significantly with $6.1 million cash raised in Q2 2020 * Strategic co-promotion partnership with Men

OpGen (NASDAQ: OPGN) will be releasing its next round of earnings this Wednesday, August 12. For all of the relevant information, here is your guide for Wednesday's Q2 earnings announcement.Earnings a

Accurate identification of antibiotic resistance markers based on the ARESdb QIAGEN CLC Module leveraging Ares Genetics’ proprietary antibiotic resistance database Pathogens correctly identified wi

GAITHERSBURG, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) -- As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press release, we have commenced marketing and prom

Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...

GAITHERSBURG, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second

Preliminary Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020 GAITHERSBURG, Md.,.

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md. , July 13, 2020 /CNW/ -- Menarini Silicon Biosystems (MSB), the pioneer of liquid biopsy and rare cell technologies, announced tod

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md., July 13, 2020 -- OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular.

-  European Investment Bank (EIB) and OpGen, Curetis GmbH and Ares Genetics GmbH enter into Amendment to the EIB Financing Agreement -  Additional EUR 5 Million Tranche With.